Clene holder SymBiosis II sells 78,679 shares
Clene Inc. insider activity: An entity associated with major shareholder Ugwumba Chidozie, identified as SymBiosis II, LLC, reported open-market sales of Clene Inc. common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Clene Inc. insider activity: An entity associated with major shareholder Ugwumba Chidozie, identified as SymBiosis II, LLC, reported open-market sales of Clene Inc. common stock. On May 1, 2026, SymBiosis II, LLC sold 5,795 shares at $6.01 per share. On May 4, 2026, it sold an additional 72,884 shares at $6.80 per share. After the May 4 transaction, SymBiosis II, LLC continued to hold 198,890 shares of Clene Inc. common stock indirectly on behalf of Ugwumba Chidozie.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 72,884 | $6.80 | $496K |
| Sale | Common Stock | 5,795 | $6.01 | $35K |
Key Figures
Key Terms
open-market sale financial
Common Stock financial
indirect financial
ten percent owner financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Clene Inc. (CLNN) report for Ugwumba Chidozie?
Are the Clene Inc. (CLNN) insider transactions direct or indirect holdings?
What type of transactions were reported in Clene Inc. (CLNN)’s Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.